Fri.Aug 11, 2023

article thumbnail

Kim Kardashian sparks debate on the benefits of full-body MRI scans

STAT

The last time Kim Kardashian posted about medical imaging, it was to prove her butt was real. Now, she’s praising its ability to find aneurysms and cancers before they turn deadly. Kardashian’s Instagram post this week about Prenuvo, which sells full-body MRI scans that can run in the thousands of dollars, has renewed a long-running debate about whether the tests are actually valuable or just run the risk of clogging hospitals with false positives and unnecessary follow-ups from we

Hospitals 246
article thumbnail

5 minutes with — Lundbeck CEO Dr. Deborah Dunsire

PharmaVoice

The long-time pharma exec on her most recent wins, her favorite rule to break and the words she lives by.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bird flu researchers turn to Finland’s mink farms, tracking a virus with pandemic potential

STAT

HELSINKI — It was the quiet that stood out to Tarja Sironen at the fur farm. A specialist in emerging infectious diseases, Sironen has conducted research at fur farms for years. She helped develop a Covid vaccine that was deployed to the country’s mink population during the pandemic. She knows the industry well.

Vaccines 246
article thumbnail

Bridging the Divide: Medical's Omnichannel Momentum

PharmExec

How pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Tuberculosis outbreak tied to bone grafts underscores shortcomings of testing

STAT

One person has died and at least four have been sickened by tuberculosis in infected bone materials, an outbreak that has cast a spotlight on the shortcomings of testing for such tissue products. It’s the second tuberculosis outbreak linked to the biomaterial device company, Aziyo Biologics. In 2021, Aziyo’s product killed eight people after orthopedic and dental surgeons unwittingly implanted infected bone grafts into patients.

243
243
article thumbnail

Antibiotic Interactions: Combinations to Avoid for Safe Medication

FADIC

Antibiotic Interactions: Avoid for Safe Medication Antibiotic Interactions: Combinations to Avoid for Safe Medication 🧵Some combinations of antibiotics and non-antibiotics that should be avoided💊🚫 1. Flucloxacillin β-lactams are considered to be less prone to drug interactions. Flucloxacillin, however, may ⬇️ tacrolimus concentration, presumably through enzyme induction The same can occur with flucloxacillin and broad-spectrum azoles (vori/posa) LINK 2

98

More Trending

article thumbnail

A Fierce Focus On Unmet Need

PharmExec

From public defender to spearheading the adoption of innovative drugs, Wendy Short Bartie, senior VP and general manager for the hematology and cell therapy division at Bristol Myers Squibb, has remained a steadfast patient advocate—working to fulfill unmet medical needs and bring treatments to as many people as possible.

98
article thumbnail

Opinion: Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death

STAT

So many promising medical innovations never reach their full potential as therapies or cures, languishing instead in a metaphoric place many of us in biotech know as “the Valley of Death.” This valley represents the gap between when a scientist makes a discovery and when that work has reached the point when a pharmaceutical company will license it, or a venture capital firm will invest in it, to get it to the point to help the patients who need it.

article thumbnail

Pharmacies to be paid for September flu jabs already booked

The Pharmacist

While the flu vaccination service will officially begin in October, pharmacies will still be paid for vaccinating eligible patients who have already booked appointments for September, NHS England (NHSE) has announced. In a letter to flu vaccination providers, NHSE asked that the adult flu vaccination programme commence from October, confirming what it had earlier told […] The post Pharmacies to be paid for September flu jabs already booked appeared first on The Pharmacist.

article thumbnail

STAT+: White House drug shortages task MIA with lawmakers while Congress works on fixes

STAT

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies. The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Overdose risk higher when opioid agonists prescribed with other medicines

The Pharmacist

The risk of overdose from prescribed medicines used to overcome drug addiction is higher when patients are taking other medication, according to a new study from the University of Manchester. In some cases, patients were more than twice as likely to be hospitalised with an overdose if they were taking opioid agonists in combination with […] The post Overdose risk higher when opioid agonists prescribed with other medicines appeared first on The Pharmacist.

94
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

178
178
article thumbnail

Total cost of antidiabetic drugs more than doubles in eight years

The Pharmacist

The total cost of non-insulin antidiabetic drugs in England has increased by 107% between 2015/16 and 2022/23, according to new figures published this week. This increase occurred at a rate ‘much greater’ than the increase in number of items prescribed, according to the NHS Business Services Authority (NHSBSA), which released the data. The total cost […] The post Total cost of antidiabetic drugs more than doubles in eight years appeared first on The Pharmacist.

article thumbnail

Journal Impact Factor

FADIC

Journal Impact Factor Journal Impact Factor: Understanding its Significance in the World of Science The Journal Impact Factor (JIF) has become a commonly used measure of a journal’s success and influence in academic publishing. The JIF is a metric that measures the frequency with which articles from a particular journal are cited within a certain period.

95
article thumbnail

Government proposes to extend pandemic vaccination regulations

The Pharmacist

The Government has launched a consultation on proposals to extend vaccination regulations adopted due to the Covid-19 pandemic. It said it wanted to provide ‘greater flexibilities for the movement and supply of certain type of vaccines’. It comes as a new strategy that will shape the future of vaccination delivery is expected to be published by the end […] The post Government proposes to extend pandemic vaccination regulations appeared first on The Pharmacist.

article thumbnail

How To Get Accurate Lab Tests When Taking Thyroid Medications

The Thyroid Pharmacist

Thyroid hormones are “Goldilocks” hormones: the dose has to be “just right” for us to feel optimal. Doses that are too high or too low can result in symptoms. I get tons of messages from people who report that they had begun to feel hypothyroid symptoms after having their thyroid medications reduced, based on a faulty lab interpretation. One lady began to lose her hair in clumps; another became nearly bedridden!

Dosage 95
article thumbnail

Pharmacy sector considers next steps amid flu vaccination change

The Pharmacist

The community pharmacy sector has welcomed NHS England (NHSE’s) decision to allow community pharmacies to proceed with flu vaccination appointments that are already booked for September. But organisations across the sector have expressed differing thoughts about what the next steps for the programme should be. The National Pharmacy Association (NPA) has continued to urge NHS […] The post Pharmacy sector considers next steps amid flu vaccination change appeared first on The Pharmacist.

article thumbnail

Pharma's ESG Equation: Materiality and Strategy are Key

PharmExec

Life sciences executives who are confronted by too many choices in launching their environmental, social, and governance programs can leverage these two foundational tools to hone in on the set of issues, actions, and disclosures they should prioritize to create value.

93
article thumbnail

Family of Henrietta Lacks sues Ultragenyx over use of HeLa cell line

BioPharma Dive

Filed in Maryland district court, the lawsuit claims the biotech unjustly profited from using HeLa cells to develop AAV vectors for its gene therapy products.

98
article thumbnail

Novartis’ remibrutinib shows promise for patients with CSU

Pharma Times

Highly selective inhibitor therapy treats patients with chronic spontaneous urticaria - News - PharmaTimes

110
110
article thumbnail

Our collaborations with Govt of India focus on building resilient healthcare systems

Express Pharma

As this will be your first official visit to India following your appointment as the Asia Area Vice President, AstraZeneca what are your plans to grow the India market share? AstraZeneca is committed to transform healthcare for billions of people. Pioneering science is accelerating our understanding of disease, helping us better predict clinical success, develop and deliver life changing medicines and increase engagement in the clinic and beyond.

article thumbnail

Atai Life delivers results from PCN-101 study

Pharma Times

Data supports further exploration of candidate as a rapid-acting anti-depressant for home use - News - PharmaTimes

102
102
article thumbnail

Sathgen completes dosing of first two cohorts of healthy volunteers with MSP008-22, a novel anti-viral molecule

Express Pharma

Sathgen Therapeutics, a division of Godavari Biorefineries, announced that they completed the dosing of the first two cohorts of healthy volunteers in a Phase 1 clinical trial with their novel chemical entity (NCE), MSP008-22. The clinical development of this drug is supported and managed by Clinexel Life Sciences, a clinical research organisation in the pharma sector.

89
article thumbnail

European Commission revokes marketing authorisation for Novartis’ crizanlizumab

European Pharmaceutical Review

The European Commission has revoked the conditional marketing authorisation (MA) for Novartis’ sickle cell medicine crizanlizumab in the European Union (EU) and EEA. The decision follows a May recommendation from the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP). Crizanlizumab is a once-a-month, humanised monoclonal antibody infusion, indicated for the prevention of recurrent vaso‑occlusive crises (pain crises) in sickle cell disease patients aged 16 yea

86
article thumbnail

The Nucleus of Future Pharma: Medical Affairs is a Central Cog in Enterprise Shift

PharmExec

Now with a seat at the table, growing accountability, and evolving competencies, medical affairs can use its far-reaching influence to change pharma for the better.

87
article thumbnail

Genprex’s Reqorsa gene therapy picks up orphan drug designation from FDA for SCLC

Pharmaceutical Technology

The latest tag adds to three fast track designations for Reqorsa, with the company initiating a Phase I/II trial in Q4 2023.

96
article thumbnail

Johnson & Johnson Announces FDA Approval of Multiple Myeloma Treatment Talvey

PharmExec

Continued approval to be based on verification and description of clinical benefit in confirmatory trials.

98
article thumbnail

Clinigen clears out cancer therapies in line with latest growth strategy

Pharmaceutical Technology

Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.

98
article thumbnail

Why Data Should Be a Top Priority

Pharmaceutical Commerce

MIT’s Barbara Wixom, PhD, outlines the importance of data-powered research in producing financial success.

98
article thumbnail

Digital as a Disguise: Beware the Illusion of an Automated Hub Experience

Drug Channels

Today’s guest post comes from Rebecca Cotton, Executive Director of Strategy & Product Innovation at Cardinal Health ™ Sonexus ™ Access and Patient Support Rebecca discusses the essential features biopharmaceutical manufacturers should seek in a digital hub that will help patients get their therapies faster. She argues that the most effective hub balances automation with the still-relevant value of human interactions.

65
article thumbnail

Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game

pharmaphorum

Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game Mike.

90
article thumbnail

Lippe Taylor Group, MedFluencers Form Strategic Health Partnership

PharmExec

Collaboration intends to inspire creativity in healthcare and pharma industries.

98
article thumbnail

A medication used for heart conditions improves the efficacy of current treatments for melanoma in mouse models

World Pharma News

A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, ​​Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d'Alacant, Valencian Community) and IRB Barcelona (Barcelona, ​​Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.

62
article thumbnail

What You Need to Know: ABS Continuous Certification Assessment in General Surgery

Board Vitals - Pharmacist

The practice of medicine is a dynamic field, constantly evolving with advances in technology, research, and best practices. As a result, board certification has become an essential part of the medical profession, ensuring that physicians stay up to date with the latest knowledge and skills. For general surgeons, the Continuous Certification Assessment (CCA) plays a vital role in maintaining their certification and providing high-quality patient care.

article thumbnail

New patent expiration for Boehringer Ingelheim drug JENTADUETO XR

Drug Patent Watch

Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are ten… The post New patent expiration for Boehringer Ingelheim drug JENTADUETO XR appeared first on DrugPatentWatch - Make Better Decisions.

52